Service and Maintenance Contract for Genomic Sequencing Platform
A Contract Award Notice
by NORTHUMBRIA UNIVERSITY
- Source
- Find a Tender
- Type
- Contract ()
- Duration
- not specified
- Value
- ___
- Sector
- MISCELLANEOUS
- Published
- 06 Jul 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
1 buyer
- Northumbria University Newcastle upon Tyne
1 supplier
- Pacific Biosciences of California California
Description
Northumbria University has procured a 5-year service, support, and maintenance contract for an existing Revio high-throughput genomic sequencing platform to support advanced molecular, environmental, and bioscience research frameworks within the Faculty of Science and Environment. This specialized multi-year service agreement is critical for ensuring the continuous, high-availability, and high-precision operational performance of complex, long-read sequencing instrumentation running critical data workflows. The contract ensures the systematic provisioning of vital maintenance parameters—including preventative maintenance visits, emergency engineering labor, certified replacement parts, proprietary consumables required for mechanical repairs, and real-time remote performance monitoring—allowing researchers to maximize instrument uptime and maintain strict data fidelity across high-throughput genomic pipelines. The contract is awarded via a formal internal procurement exemption as the sequencing platform relies entirely on proprietary technology and closed-source software architectures. Consequently, the original equipment manufacturer (OEM) is the sole authorized provider capable of supplying certified replacement parts, executing specialized engineering calibrations, and providing remote diagnostic support. No alternative provider exists with the technical capacity or legal authorization to service the asset without compromising instrument validation, operational warranties, or downstream research data fidelity.
Award Detail
| 1 | Pacific Biosciences of California (California)
|
CPV Codes
- None found
Legal Justification
The direct award is justified under Schedule 5 of the Procurement Act 2023 due to exclusive rights and technical reasons: Intellectual Property and Exclusive Rights: The genomic sequencing platform relies entirely on proprietary, patented technology and closed-source software architectures owned exclusively by the original equipment manufacturer (OEM). No third-party providers hold the legal licenses or authorizations required to access, update, or modify the system's core operating infrastructure. Technical Reasons: The OEM is the sole authorized provider globally with the specialized technical capacity, certified engineering tooling, and remote diagnostic systems required to service this instrument. Utilizing an alternative provider would invalidate manufacturer operational warranties, breach mandatory instrument calibration protocols (such as laser alignment), and fatally compromise downstream research data fidelity and scientific validation.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-06b36e
- FTS 063106-2026